Close [X]
Companies & Industry »Company News»Company News Details
Company News Details

BSE   07 Dec 16 | 04:01 PM

391.30 -3.9 (-0.99%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   07 Dec 16 | 03:56 PM

391.05 -3.1 (-0.79%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 399.60 (-2.08%)
1 Month : Rs 375.10 (4.32%)
1 Year : Rs 393.65 (-0.60%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

Widgets Magazine

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Widgets Magazine

Sensex

Company Price Gain (%)
Adani Ports277.101.86
H D F C1,265.451.74
Hero Motocorp3,240.001.31
Tata Motors445.250.88
M & M1,184.250.77

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine